Van Hulzen Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Van Hulzen Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,751	Closed	-$631K	–	322
2020 Q4	$631K	Buy	8,751 +274	+3%	+$14.3K	0.1%	121
2020 Q3	$386K	Sell	8,477 -847	-9%	-$35.4K	0.06%	162
2020 Q2	$421K	Buy	9,324 +3,045	+48%	+$136K	0.06%	147
2020 Q1	$242K	Sell	6,279 -7,379	-54%	-$340K	0.05%	212
2019 Q4	$632K	Buy	+13,658	New	+$591K	0.12%	120

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Van Hulzen Asset Management's BEAT Position: Q1 2021 in Review

Van Hulzen Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 8,751 shares — an estimated $631K sold.

Van Hulzen Asset Management first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $632K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Van Hulzen Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Van Hulzen Asset Management sold 8,751 BioTelemetry, Inc. shares in Q1 2021, an estimated $631K.
Van Hulzen Asset Management first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Van Hulzen Asset Management's BioTelemetry, Inc. position peaked at $632K in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Van Hulzen Asset Management's 13F filing for Q1 2021, filed 12 May 2021.